- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02348710
Exercise Intervention for Cancer Survivors
January 26, 2017 updated by: Duke University
Exercise Outcome Expectations Among Breast Cancer Survivors
This randomized controlled trial will test a multicomponent intervention to increase exercise Outcome Expectations (OEs) and assess effects of OE changes on exercise intentions and levels of exercise.
Sixty early stage breast cancer survivors will be recruited from the Duke Cancer Institute.
Participants will be randomized to the exercise OE intervention or an attention control group.
Both groups will receive the American Cancer Society diet and exercise guidelines and an accelerometer.
The intervention group will also receive an OE workbook containing self-directed activities to increase OEs by focusing on OE importance (value placed on the outcome(s)), certainty (perceived probability outcome(s) will occur); and accessibility (frequency with which the outcome(s) are thought of).
The attention control group will receive a workbook containing the same activities focused on diet, rather than exercise.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will test a theory-based intervention to increase levels of exercise among breast cancer survivors, in order to help them self-manage their long-term treatment side effects.
The study focuses on outcome expectations (OEs), a significant yet understudied construct that is central to most behavior change theories.
OEs refer to what people expect to obtain or avoid by engaging in a behavior; thus, people exercise because they believe it will produce desired outcomes.
This randomized controlled trial will test a multicomponent intervention to increase exercise OEs and assess effects of OE changes on exercise intentions and levels of exercise.
Sixty early stage (IA to IIB) inactive breast cancer survivors will be recruited from the Duke Cancer Institute.
Participants will be randomized to the exercise OE intervention or an attention control group.
Both groups will receive the American Cancer Society diet and exercise guidelines and an accelerometer.
The intervention group will also receive an OE workbook containing self-directed activities to increase OEs by focusing on OE importance (value placed on the outcome(s)), certainty (perceived probability outcome(s) will occur); and accessibility (frequency with which the outcome(s) are thought of).
The attention control group will receive a workbook containing the same activities focused on diet, rather than exercise.
OE importance, OE certainty, OE accessibility, exercise intentions, exercise, and self-efficacy (a potential co-variate) will be assessed through online surveys at baseline, 4-, 8-, and 12-weeks post-intervention.
At each time point, accelerometer data will be collected as an objective exercise measure.
Specific aims of the study are to: (1) examine trajectories of OE importance, certainty and accessibility between participants in the OE intervention arm compared to participants in the attention control arm, across four time points: baseline, 4-, 8- and 12-weeks post-intervention; and (2) examine trajectories of exercise intentions and total weekly minutes of exercise, between participants in the OE intervention arm compared to participants in the attention control arm, across four time points: baseline, 4, 8 and 12 weeks post-intervention.
If the intervention increases exercise among breast cancer survivors it may lead to improved survivorship duration and quality of life.
The intervention can be implemented readily in clinic settings to support survivors to exercise more and thus experience better long-term outcomes.
This study also provides a foundation for a developing a nurse scientist's program of research focused on designing theory-based exercise interventions for chronically ill populations.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- stage 1A - 2B breast cancer diagnosis;
- 2 months - 10 years status post surgery, radiation and chemotherapy;
- inactive (self-reported ≤ 150 min/wk moderate - strenuous-intensity exercise);
- no evidence of cancer recurrence;
- no pre-existing medical condition(s) that preclude adherence to an unsupervised exercise program (e.g., severe orthopedic conditions, scheduled hip or knee replacement within 6 months, paralysis and/or dementia, unstable angina, history of myocardial infarction, congestive heart failure);
- English-speaking and writing;
- access and ability to use a computer for completion of online measures; and
- possession of smartphone
Exclusion Criteria:
None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: exercise outcome expectation workbook
Intervention arm participants will receive: 1) the ACS exercise and diet guidelines; and 2) an exercise outcome expectation workbook.
The workbook contains self-directed activities to increase OE importance, certainty, and accessibility.
The workbook will aim to make participants aware of the breadth and depth of OEs by first providing a global overview of the many positive exercise outcomes breast cancer survivors may experience.
Importance will be increased through elaboration of why outcomes are important to the participant; and certainty will be increased by narrative messages from other breast cancer survivors and an oncologist.
Accessibility will be increased by having the participant think about the association between exercise and its outcomes.
|
The workbook will aim to make participants aware of the breadth and depth of OEs by first providing a global overview of the many and diverse positive outcomes breast cancer survivors may experience.
Participants will then be asked to focus on the three OEs they would most like to experience.
Each section of the OE guide contains activities to target specific OE dimensions.
Importance will be increased through elaboration of why outcomes are important to the participant; and certainty will be increased by narrative messages from other breast cancer survivors and an oncologist.
Accessibility will be increased by having the participant think about the association between exercise and its outcomes
|
|
Active Comparator: diet workbook
Attention control participants will receive via mail 1) the ACS exercise and diet guidelines; and 2) a diet workbook.
The diet workbook contains the same activities as the exercise outcome expectation workbook but is focused on diet instead of exercise.
|
The workbook will contain the same activities as the intervention workbook but be focused on diet instead of exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in OE importance, as measured by questionnaire
Time Frame: baseline 4- 8- and 12-weeks post intervention
|
baseline 4- 8- and 12-weeks post intervention
|
|
change in OE accessibility, as measured by questionnaire
Time Frame: baseline 4- 8- and 12-weeks post intervention
|
baseline 4- 8- and 12-weeks post intervention
|
|
change in OE certainty, as measured by questionnaire
Time Frame: baseline 4- 8- and 12-weeks post intervention
|
baseline 4- 8- and 12-weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in intentions to exercise, as measured by questionnaire
Time Frame: baseline 4- 8- and 12-weeks post intervention
|
baseline 4- 8- and 12-weeks post intervention
|
|
change in total weekly minutes of exercise
Time Frame: baseline 4- 8- and 12-weeks post intervention
|
baseline 4- 8- and 12-weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2015
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
January 23, 2015
First Submitted That Met QC Criteria
January 23, 2015
First Posted (Estimate)
January 28, 2015
Study Record Updates
Last Update Posted (Estimate)
January 27, 2017
Last Update Submitted That Met QC Criteria
January 26, 2017
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- Pro00059469
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Neoplasms | Colon Neoplasms | Metagenome | MicrobiotaChina
-
European Association for Endoscopic SurgeryWithdrawn
-
Moscow Clinical Scientific CenterRecruitingCecal Neoplasms | Colonic Neoplasms MalignantRussian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruitingPeritoneal CarcinomatosisUnited States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingColonic NeoplasmsChina
-
Nanjing Medical UniversityNot yet recruitingMalignant Meningioma
-
Joshua PalmerRayzeBio, Inc.RecruitingRecurrent MeningiomaUnited States
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRegeneron PharmaceuticalsNot yet recruiting
-
Royal North Shore HospitalNorthern Sydney and Central Coast Area Health ServiceRecruiting
Clinical Trials on Exercise OE workbook
-
Instituto Ecuatoriano de Enfermedades DigestivasCompletedGERD | Non Erosive Reflux DiseaseEcuador
-
Shandong UniversityUnknownOptical Enhancement EndoscopyChina
-
Changhai HospitalFirst People's Hospital of Hangzhou; Tongji Hospital; Qilu Hospital of Shandong... and other collaboratorsUnknown
-
The University of Tennessee, KnoxvilleBreast Cancer Research FoundationActive, not recruitingBreast Cancer | Gynecologic Cancer | Sexual Dysfunction | Partner CommunicationUnited States
-
Northwestern UniversityCompletedDisorder Related to Renal Transplantation | Unspecified Complications of Kidney TransplantUnited States
-
Limbic LimitedCompletedMental Health IssueUnited Kingdom
-
Emory UniversityGeorgia Center for Diabetes Translation ResearchCompleted
-
City University of Hong KongStanford University; Harvard UniversityCompletedMental Health WellnessColombia, Indonesia, South Africa, Ukraine
-
Weill Medical College of Cornell UniversityUniversity of Iowa; National Institute on Aging (NIA); Cornell University; Rutgers...TerminatedChronic Pain | DementiaUnited States